Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)

HKD 23.15

(-0.22%)

Market Cap (In HKD)

899 Million

Revenue (In HKD)

232.34 Million

Net Income (In HKD)

-94.01 Million

Avg. Volume

6641.00

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
12.1-29.8
PE
-
EPS
-
Beta Value
0.689
ISIN
CNE100004MN5
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Guohui Wang
Employee Count
-
Website
https://www.heartcare.com.cn
Ipo Date
2021-08-20
Details
Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.